Home > Events
Programs & Events
Loading view.
Biliary Atresia Awareness Day
VirtualJoin us in recognizing Biliary Atresia Awareness Day (Dec 2nd) featuring panel discussions and patient stories on topics important to you.
ALF’s Year-End Advocacy Briefing
VirtualSave the date for our Year-End Advocacy Briefing.
New Nomenclature for Fatty Liver Disease
On-DemandRotonya Carr, MD, FACP, Division Head of Gastroenterology at University of Washington joined us for a conversation about the changes in terminology for fatty liver disease and what this means for patients.
Overcoming Stigma and Advocating for Equitable Care in Liver Cancer
On-DemandWatch a panel of liver cancer specialists from Memorial Sloan Kettering in a 1-hour on-demand webinar on new and emerging treatments for liver cancer.
Decoding the Nuances of Diagnosis and Emerging Therapeutic Options in HCC
On-DemandJoin us for a timely CME session available on-demand with leading oncologists to examine the latest diagnostic and treatment strategies for hepatocellular carcinoma (HCC).
The Involved Patient: Making the Most of Your Medical Visits
On-DemandWatch this on-demand program, which will empower you to actively participate in your medical care and provide you with the tools to not only be a patient or caregiver, but a partner with your health care team in your journey to good health.
Houston 5K
Houston, TXHouston Full & Half Marathon
Houston, TX
Liver Life Walk Arizona
Richmond, Virginia
Understanding the HER2 Story in Gastrointestinal Malignancies: A GEA and BTC Focus
VirtualWe've collaborated with Medscape Oncology Global and Hope for Stomach Cancer to present a CME opportunity for health care professionals seeking to gain a better understanding of emerging anti-human epidermal growth factor receptor 2 (HER2) therapies used to manage gastroesophageal adenocarcinoma (GEA) and biliary tract cancer (BTC). Register and attend today.
Life with Biliary Atresia and Beyond: Progressive Familial Intrahepatic Cholestasis
VirtualWe will cover the definition, cause, new approaches to diagnosis and novel therapies of Progressive Familial Intrahepatic Cholestasis.